Brokerages Set Nestlé (VTX:NESN) Target Price at CHF 111.87

Share on StockTwits

Nestlé (VTX:NESN) has been assigned a consensus rating of “Buy” from the fifteen research firms that are presently covering the stock, MarketBeat reports. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is CHF 111.87.

Several equities research analysts have weighed in on the stock. HSBC set a CHF 109 price target on shares of Nestlé and gave the company a “neutral” rating in a research note on Friday, October 18th. Credit Suisse Group set a CHF 93 target price on shares of Nestlé and gave the stock a “sell” rating in a research report on Tuesday, October 15th. Barclays set a CHF 115 target price on shares of Nestlé and gave the stock a “buy” rating in a research report on Thursday, September 26th. UBS Group set a CHF 117 target price on shares of Nestlé and gave the stock a “buy” rating in a research report on Friday, October 18th. Finally, Goldman Sachs Group set a CHF 119 target price on shares of Nestlé and gave the stock a “buy” rating in a research report on Thursday, October 17th.

Nestlé has a 52 week low of CHF 73.34 and a 52 week high of CHF 86.40.

About Nestlé

Nestle SA is a nutrition, health and wellness company. The Company’s segments are Zone Europe, Middle East and North Africa (EMENA); Zone Americas (AMS); Zone Asia, Oceania and sub-Saharan Africa (AOA); Nestle Waters; Nestle Nutrition, and Other Businesses. The Company operates in the United States, Greater China Region, Switzerland and Rest of the World.

Recommended Story: How is the S&P 500 index different from the DJIA?

Analyst Recommendations for Nestlé (VTX:NESN)

Receive News & Ratings for Nestlé Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nestlé and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.